In Europe alone, hundreds of different variants of the new coronavirus SARS-CoV-2 are currently circulating, distinguished by mutations in their genomes. However, only very few of these variants have spread as successfully…

Prof. Marek Basler at the Biozentrum, University Basel, has been awarded the 2018 EMBO Gold Medal jointly with Dr. Melina Schuh from the Max Planck Institute for Biophysical Chemistry in Göttingen, Germany. The infection…

Diabetes is a medical condition in which the body is unable to keep blood sugar in a healthy range. Normally, the pancreas produces sufficient insulin to regulate the blood sugar level and maintain homeostasis. However, in…

ARTIDIS AG announced the successful completion of its clinical study “NANO”, which was performed to evaluate the utility and the sensitivity of a nanomechanical biomarker, developed by ARTIDIS, for breast cancer diagnosis.…

With this award, the Charles Rodolphe Brupbacher Foundation honors Prof. Michael N. Hall's outstanding basic research which led to the discovery of the protein Target of Rapamycin, or TOR for short. TOR controls cell growth…

T3 Pharmaceuticals is one of top five startup companies selected by the W.A. de Vigier Foundation. The winning companies were selected from a record number of 256 applications in a multi-step process. At the award ceremony…

In the upcoming Biozentrum Lecture, Prof. Christer Betsholtz from the University of Uppsala and the “Karolinska Institutet Stockholm” will talk about the challenges of identifying and characterizing a very inhomogeneous cell…

On July 23, 2017, Prof. Björn Burmann, a recent member of the Biozentrum, University of Basel, has received the Anatole Abragam Prize at the ISMAR Conference 2017 in Canada, together with Dr. Loren Andreas from the Max…

For the high school students in Basel, July is Summer Holiday time. But instead of chilling and swimming in the Rhine, sixteen selected gymnasium students will discover who and what frolics about in the river during their…

Prof. Richard Neher, who was just recently appointed to the Biozentrum of the University of Basel, and Prof. Trevor Bedford competed successfully with their open access website “ nextstrain.org ” against two other teams in…